Upstream Bio, Inc.
UPB
$8.95
-$0.16-1.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.20% | -27.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.20% | -27.11% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -2.20% | -27.11% | |||
| SG&A Expenses | 20.28% | -25.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.60% | -14.94% | |||
| Operating Income | -22.03% | 14.69% | |||
| Income Before Tax | -25.81% | 15.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.81% | 15.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.81% | 15.56% | |||
| EBIT | -22.03% | 14.69% | |||
| EBITDA | -22.02% | 14.71% | |||
| EPS Basic | -25.44% | 15.81% | |||
| Normalized Basic EPS | -25.44% | 15.80% | |||
| EPS Diluted | -25.44% | 15.81% | |||
| Normalized Diluted EPS | -25.44% | 15.80% | |||
| Average Basic Shares Outstanding | 0.29% | 0.30% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||